Pharmacokinetic and Safety Trial to Determine the Appropriate Dose for Pediatric Patients With Multidrug Resistant Tuberculosis
Condition(s):Multidrug Resistant Tuberculosis; PediatricLast Updated:January 30, 2018Completed
Hide Studies Not Open or Pending
Condition(s):Multidrug Resistant Tuberculosis; PediatricLast Updated:January 30, 2018Completed
Condition(s):Multi-drug Resistant TuberculosisLast Updated:February 25, 2021Completed
Condition(s):TuberculosisLast Updated:October 14, 2021Unknown status
Condition(s):Multi-drug Resistant TuberculosisLast Updated:July 27, 2021Unknown status
Condition(s):Tuberculosis, Multidrug-ResistantLast Updated:November 1, 2021Completed
Condition(s):Tuberculosis, Multidrug-ResistantLast Updated:October 10, 2019Unknown status
Condition(s):TuberculosisLast Updated:April 29, 2014Completed
Condition(s):Multidrug Resistant TuberculosisLast Updated:April 7, 2023Active, not recruiting
Condition(s):Multidrug Resistant TuberculosisLast Updated:November 23, 2020Completed
Condition(s):Multi-drug Resistant Tuberculosis; Extensively Drug-Resistant Tuberculosis; Pulmonary TuberculosesLast Updated:May 14, 2021Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.